Guide to Ozempic/Wegovy Vision Loss Lawsuits and Settlements. by: Martin P. Schrama, Stefanie Colella-Walsh of Stark & Stark - Personal Injury Law Journal. Sunday, June 22, 2025.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...

Watch this first: <a href=" On the 28th of April 2024, highly respected youtube channel GAMERSNEXUS created a one hour video delving deep into the practises of Slovenian cooling company EKWB.

More than a dozen lawsuits filed in New York and New Jersey claim that weight-loss drugs like Wegovy and Ozempic caused ...

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...

A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...

Some blind vision loss cases have been linked to the use of weight-loss jabs, including Ozempic, so caution is recommended by ...

Nick Carter's recent slim-down has caused a stir among his fans, but a source exclusively tells Us Weekly that he's not on ...

Both Wegovy and Ozempic were on the U.S. Food and Drug Administration's drug shortage list from March 2022 to February 2025. ... Novo said it has filed nearly 120 lawsuits across 34 states, ...

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

Hims & Hers (HIMS) stock is nosediving after Novo Nordisk (NVO) ended its deal with the company over continued sales of ...